[Clinical Effects of Pomalidomide-Based Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma].
The pomalidomide-based regimen has a good clinical effect and safety in the treatment of RRMM.
Authors
- Lu-Yao Zhu (ORCID: https://orcid.org/0000-0001-8341-2024)
- Xiankai Liu (ORCID: https://orcid.org/0000-0002-0111-5876)
- Ling-Xiu Zhang
- Yan Guo (ORCID: https://orcid.org/0000-0001-5252-3960)
- Yan Huang (ORCID: https://orcid.org/0000-0002-5588-0274)
- Guoqing Lyu (ORCID: https://orcid.org/0009-0009-7650-1040)
- Man Yang
Institutions
- Henan Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.02.017
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article